A phase II, multicenter, open-labeled study of immunotherapy with autologous dexosomes for patients with stage IV melanoma
Phase of Trial: Phase II
Latest Information Update: 13 Oct 2005
At a glance
- Drugs Melanoma vaccine (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 13 Oct 2005 New trial record.